Standard Operating Procedure to Ensure Study Staff Role Clarity in BA/BE Clinical Trials
Department | BA-BE Studies |
---|---|
SOP No. | SOP/BA-BE/145/2025 |
Supersedes | SOP/BA-BE/145/2022 |
Page No. | Page 1 of 9 |
Issue Date | 17/04/2025 |
Effective Date | 20/04/2025 |
Review Date | 17/04/2026 |
1. Purpose
To ensure clear definition, documentation, communication, and adherence to roles and responsibilities of all personnel involved in BA/BE clinical trials, thereby promoting accountability, reducing errors, and supporting GCP compliance.
2. Scope
This SOP applies to all clinical, bioanalytical, QA, data management, pharmacy, and administrative staff associated with the conduct of BA/BE studies at the clinical site or sponsor organization.
3. Responsibilities
- Clinical Operations Manager: Oversees role allocation and approval of role responsibility matrices.
- Principal Investigator (PI): Ensures that responsibilities are aligned with protocol requirements and regulatory expectations.
- HR/Training Coordinator: Maintains training records and ensures all staff are aware of their designated responsibilities.
- Department Heads: Validate role-specific SOPs and clarify team deliverables.
4. Accountability
The Clinical Research Director or Head of Clinical Operations is accountable for ensuring effective implementation of this SOP and resolution of any role-based conflict or ambiguity.
5. Procedure
5.1 Role Identification and Allocation
- Prepare a Role and Responsibility Matrix (Annexure-1) prior to study initiation based on protocol tasks, site needs, and ICH-GCP guidelines.
- Define key positions including but not limited to:
- Principal Investigator (PI)
- Sub-Investigator
- Study Coordinator
- Pharmacist
- Phlebotomist
- Bioanalytical Scientist
- Quality Assurance Officer
- Each role should have defined primary and secondary responsibilities documented and approved by the Department Head.
5.2 Communication of Roles
- Conduct a Study Kickoff Meeting where the role matrix is presented and explained to all staff.
- Circulate signed copies of the matrix to all team members and post it in the study control room.
- Staff must acknowledge their understanding of roles by signing the Role Acknowledgment Log (Annexure-2).
5.3 Role-Based Training and Competency
- Assign training modules based on specific roles using applicable SOPs and study protocol sections.
- Training must be documented in the Staff Training Log (Annexure-3) with trainer signature and date.
- Conduct assessments, if required, for critical roles (e.g., dosing, sample processing, SAE reporting).
5.4 Handling Role Ambiguities or Overlaps
- In case of ambiguity:
- Raise a formal clarification request to the Clinical Operations Manager.
- Update matrix and communicate revised roles to all stakeholders.
- In case of staff unavailability, alternate persons should be cross-trained and designated in the matrix.
5.5 Monitoring and Compliance
- QA team to verify role compliance during study audits and monitoring visits.
- Any observed deviation from designated roles must be documented and addressed via CAPA.
- Updates to roles or reassignment must be approved by PI and documented in an updated matrix version.
5.6 Documentation and Archiving
- All role-related documents must be filed in the study-specific Trial Master File (TMF).
- Archived records must be retained for at least 5 years post-study or as per regulatory requirements.
6. Abbreviations
- BA/BE: Bioavailability/Bioequivalence
- PI: Principal Investigator
- QA: Quality Assurance
- CAPA: Corrective and Preventive Action
- TMF: Trial Master File
7. Documents
- Role and Responsibility Matrix – Annexure-1
- Role Acknowledgment Log – Annexure-2
- Staff Training Log – Annexure-3
8. References
- ICH E6(R2) – Good Clinical Practice
- Schedule Y – Indian GCP Guidelines
- Company Training Policy and HR SOPs
9. SOP Version
Version: 2.0
10. Approval Section
Prepared By | Checked By | Approved By | |
---|---|---|---|
Signature | |||
Date | |||
Name | |||
Designation | |||
Department |
11. Annexures
Annexure-1: Role and Responsibility Matrix
Role | Primary Responsibilities | Backup Staff |
---|---|---|
Pharmacist | IMP receipt, labeling, storage, accountability | Sunita Reddy |
PI | Subject safety, protocol compliance | Dr. Vinay Pawar |
Annexure-2: Role Acknowledgment Log
Name | Designation | Role | Signature | Date |
---|---|---|---|---|
Rajesh Kumar | Study Coordinator | Subject randomization, CRF updates | Signed | 15/04/2025 |
Annexure-3: Staff Training Log
Staff Name | Role | Training Topic | Date | Trainer | Remarks |
---|---|---|---|---|---|
Ajay Verma | Phlebotomist | PK sample collection | 14/04/2025 | QA Officer | Trained |
Revision History:
Revision Date | Revision No. | Details | Reason | Approved By |
---|---|---|---|---|
01/01/2022 | 1.0 | Initial release | Role management SOP introduction | QA Head |
17/04/2025 | 2.0 | Expanded procedure and annexures for training and role sign-off | Audit preparation | QA Head |